Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Equity Ratio: 2010-2024

Historic Equity Ratio for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to 0.2.

  • Cryo Cell International's Equity Ratio fell 5458.07% to 0.23 in Q3 2025 from the same period last year, while for Aug 2025 it was 0.06, marking a year-over-year decrease of 5226.98%. This contributed to the annual value of 0.2 for FY2024, which is 1980.54% down from last year.
  • Latest data reveals that Cryo Cell International reported Equity Ratio of 0.2 as of FY2024, which was down 1980.54% from 0.17 recorded in FY2023.
  • Cryo Cell International's Equity Ratio's 5-year high stood at 0.07 during FY2021, with a 5-year trough of 0.2 in FY2024.
  • For the 5-year period, Cryo Cell International's Equity Ratio averaged around 0.08, with its median value being 0.06 (2020).
  • Per our database at Business Quant, Cryo Cell International's Equity Ratio soared by 21957.23% in 2021 and then crashed by 62604.52% in 2023.
  • Annual analysis of 5 years shows Cryo Cell International's Equity Ratio stood at 0.06 in 2020, then skyrocketed by 219.57% to 0.07 in 2021, then crashed by 134.06% to 0.02 in 2022, then tumbled by 626.05% to 0.17 in 2023, then dropped by 19.81% to 0.2 in 2024.
  • Its Equity Ratio stands at 0.2 for FY2024, versus 0.17 for FY2023 and 0.02 for FY2022.